World's Best Scientists 2026 revealed!
E. William St. Clair

E. William St. Clair

D-Index & Metrics

Immunology

D-Index
69
Citations
29246
World Ranking
2466
National Ranking
1178

E. William St. Clair publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where E. William St. Clair sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 189 publications — 30th percentile

30% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

E. William St. Clair D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where E. William St. Clair sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 69 D-Index — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

E. William St. Clair is affiliated with Duke University in the United States and has a research focus predominantly within the field of Medicine, with 62 publications attributed to this area. Their work spans multiple specialized subfields, including Genetics, Pulmonary and Respiratory Medicine, Rheumatology, Physiology, and Immunology.

The scholar's primary topics of research include:

  • Vasculitis and related conditions
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Salivary Gland Disorders and Functions
  • Chronic Lymphocytic Leukemia Research
  • Rheumatoid Arthritis Research and Therapies
  • Lymphoma Diagnosis and Treatment
  • Monoclonal and Polyclonal Antibodies Research

The most frequent venues for publication are:

  • Arthritis & Rheumatology
  • Annals of the Rheumatic Diseases
  • Arthritis Care & Research
  • JCI Insight
  • Frontiers in Immunology

E. William St. Clair's recent articles include the following:

  • "CD40 ligand antagonist dazodalibep in Sjögren's disease: a randomized, double-blinded, placebo-controlled, phase 2 trial" (2024, Nature Medicine)
  • "2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis" (2021, Arthritis Care & Research)
  • "2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis" (2021, Arthritis & Rheumatology)
  • "Efficacy and safety of abatacept in active primary Sjögren's syndrome: results of a phase III, randomised, placebo-controlled trial" (2020, Annals of the Rheumatic Diseases)
  • "Consensus Guidelines for Evaluation and Management of Pulmonary Disease in Sjögren's" (2020, CHEST Journal)

Their collaborations are regularly with a consistent group of co-authors, including:

  • Carol A. Langford
  • Robert Spiera
  • Philip Seo
  • Ulrich Specks
  • Peter A. Merkel

Best Publications

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial

    E William St Clair;Désirée M F M van der Heijde;Josef S Smolen;Ravinder N Maini

  • Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells

    Yohei Iwata;Takashi Matsushita;Mayuka Horikawa;David J. DiLillo

  • 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

    Liana Fraenkel;Joan M Bathon;Bryant R England;E William St Clair

  • 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis: ACR RA Treatment Recommendations

    Jasvinder A. Singh;Kenneth G. Saag;S. Louis Bridges;Elie A. Akl

  • Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies

    Barton F. Haynes;Judith Fleming;E. William St. Clair;Herman Katinger

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • The relationship of serum infliximab concentrations to clinical improvement in rheumatoid arthritis: results from ATTRACT, a multicenter, randomized, double-blind, placebo-controlled trial.

    E. William St.Clair;Carrie L. Wagner;Adedigbo A. Fasanmade;Benjamin Wang

  • Predictors of joint damage in patients with early rheumatoid arthritis treated with high‐dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

    Josef S. Smolen;Désirée M. F. M. Van Der Heijde;E. William St.Clair;Paul Emery

  • A disease-specific activity index for Wegener's granulomatosis: Modification of the Birmingham Vasculitis Activity Score

    John H. Stone;Gary S. Hoffman;Peter A. Merkel;Yuan I. Min

  • A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: The Treatment of Early Aggressive Rheumatoid Arthritis trial

    Larry W. Moreland;James R. O'Dell;Harold E. Paulus;Jeffrey R. Curtis

  • B-lymphocyte contributions to human autoimmune disease.

    Koichi Yanaba;Jean-David Bouaziz;Takashi Matsushita;Cynthia M. Magro

  • Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review

    Joel M. Kremer;Graciela S. Alarcón;Michael E. Weinblatt;Mari V. Kaymakcian

  • Risk Factors for Methotrexate-Induced Lung Injury in Patients with Rheumatoid Arthritis: A Multicenter, Case-Control Study

    Graciela S. Alarcon;Joel M. Kremer;Maurizio Macaluso;Michael E. Weinblatt

  • CTLA4Ig: bridging the basic immunology with clinical application.

    Jeffrey A. Bluestone;E. William St. Clair;E. William St. Clair;Laurence A. Turka;Laurence A. Turka

  • ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis.

    Javier D. Finkielman;Augustine S. Lee;Amber M. Hummel;Margaret A. Viss

  • Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus.

    Glinda S. Cooper;Mary Anne Dooley;Edward L. Treadwell;E. William St. Clair

  • Brief communication: High incidence of venous thrombotic events among patients with Wegener granulomatosis - The Wegener's clinical occurrence of thrombosis (WeCLOT) study

    Peter A. Merkel;Grace H. Lo;Janet T. Holbrook;Andrea K. Tibbs

  • Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double-blind, placebo-controlled trial

    Martha L. Barnett;Joel M. Kremer;E. William St. Clair;Daniel O. Clegg

  • A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis

    Nathan Vastesaeger;Stephen Xu;Daniel Aletaha;E. William St Clair

  • Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

    Javier D. Finkielman;Peter A. Merkel;Darrell Schroeder;Gary S. Hoffman

  • Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type

    Sebastian Unizony;Miguel Villarreal;Eli M Miloslavsky;Na Lu

Frequent Co-Authors

Peter A. Merkel
Peter A. Merkel University of Pennsylvania
John H. Stone
John H. Stone Harvard University
Ulrich Specks
Ulrich Specks Mayo Clinic
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
David S. Pisetsky
David S. Pisetsky Duke University
Alfred Mahr
Alfred Mahr Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career within the field of Immunology, pursuing related online degrees can provide valuable opportunities. Many students start with foundational programs such as online BSN programs for non nurses. These programs are designed to help individuals without prior nursing experience enter healthcare, opening doors to specializations including immunology.

As students progress, accelerated pathways such as accelerated RN to NP programs offer a fast-tracked route to becoming a nurse practitioner. This advancement allows for deeper clinical roles related to immune system disorders and treatments.

Specialized certification, like the acute care certification for FNP, is another crucial step for nurse practitioners aiming to work with critical immunological conditions in acute care settings. Certification enhances clinical expertise and marketability.

Career growth is also reflected in compensation, and understanding the doctor of nursing practice salary landscape can help students make informed decisions about their educational investments and career trajectories in immunology-related nursing.

Best Scientists Citing E. William St. Clair

Trending Scientists

Recently Published Articles